Despite the current lack of evidence that screening for prostate cancer prolongs survival and/or improves quality-of-life, PSA screening may well increase in the UK, as men become more aware of prostate cancer and demand PSA testing from their GPs (Donovan et al, 2001). Here, KLK3 is linked to Familial prostate cancer.